A platform with a mapping system and a large-tip catheter with dual pulsed field and radiofrequency energies was noninferior to a conventional radiofrequency ablation system for treatment of persistent atrial fibrillation, data show. For the SPHERE Per-AF noninferiority trial, presented at Heart Rhythm 2024 and simultaneously published in Nature Medicine, the researchers randomly assigned 420
Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Israel transplants miniature pacemakers in patients ynetnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ynetnews.com Daily Mail and Mail on Sunday newspapers.